Human brain imaging and substance abuse

Current Opinion in Pharmacology

Volumn 5, Issue 1, 2005, Pages 42-46

  Lingford Hughes, Anne ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; BUPRENORPHINE; CARBON 11; COCAINE; CYCLOFOXY; DIPRENORPHINE; DOPAMINE; DOPAMINE 2 RECEPTOR; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 123; KAPPA OPIATE RECEPTOR; METHADONE; METHAMPHETAMINE; METHYLPHENIDATE; MU OPIATE RECEPTOR; NEUROTRANSMITTER; NICOTINE; OPIATE DERIVATIVE; OPIATE RECEPTOR; OXYGEN 15; PLACEBO; RACLOPRIDE; SEROTONIN TRANSPORTER; TRACER;

BRAIN FUNCTION; DOPAMINE RELEASE; DRUG EFFICACY; DRUG RECEPTOR BINDING; EXPOSURE; FRONTAL CORTEX; HUMAN; NEUROIMAGING; NEUROPHARMACOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPIATE ADDICTION; PHARMACOLOGICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANCE ABUSE;

BRAIN; HUMANS; NEUROPHARMACOLOGY; POSITRON-EMISSION TOMOGRAPHY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 12344289349     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.10.002     Document Type: Review

References (38)

1. N.D. Volkow J.S. Fowler G.J. Wang R.Z. Goldstein Role of dopamine, the frontal cortex and memory circuits in drug addiction: Insight from imaging studies Neurobiol Learn Mem 78 2002 610-624
2. N.D. Volkow J.S. Fowler G.J. Wang The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies Neuropharmacology 47 2004 3-13
3. R.Z. Goldstein N.D. Volkow Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex Am J Psychiatry 159 2002 1642-1652
4. N.D. Volkow J.S. Fowler Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex Cereb Cortex 10 2000 318-325
5. E.D. London M. Ernst S. Grant K. Bonson A. Weinstein Orbitofrontal cortex and human drug abuse: Functional imaging Cereb Cortex 10 2000 334-342
6. D.L. Due S.A. Huettel W.G. Hall D.C. Rubin Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging Am J Psychiatry 159 2002 954-960
7. A.L. Brody M.A. Mandelkern E.D. London A.R. Childress G.S. Lee R.G. Bota M.L. Ho S. Saxena L.R. Baxter Jr. D. Madsen M.E. Jarvik Brain metabolic changes during cigarette craving Arch Gen Psychiatry 59 2002 1162-1172
8. M.R. Daglish A. Weinstein A.L. Malizia S. Wilson J.K. Melichar S. Britten C. Brewer A. Lingford-Hughes J.S. Myles P. Grasby D.J. Nutt Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects Am J Psychiatry 158 2001 1680-1686
9. M.R. Daglish A. Weinstein A.L. Malizia S. Wilson J.K. Melichar A. Lingford-Hughes J.S. Myles P. Grasby D.J. Nutt Functional connectivity analysis of the neural circuits of opiate craving: 'more' rather than 'different'? Neuroimage 20 2003 1964-1970
10. H. Myrick R.F. Anton X. Li S. Henderson D. Drobes K. Voronin M.S. George Differential brain activity in alcoholics and social drinkers to alcohol cues: Relationship to craving Neuropsychopharmacology 29 2004 393-402
11. S.M. Grusser J. Wrase S. Klein D. Hermann M.N. Smolka M. Ruf W. Weber-Fahr H. Flor K. Mann D.F. Braus A. Heinz Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics Psychopharmacology (Berl) 175 2004 296-302
12. S.J. Wilson M.A. Sayette J.A. Fiez Prefrontal responses to drug cues: A neurocognitive analysis Nat Neurosci 7 2004 211-214
13. N.D. Volkow G.J. Wang Y. Ma J.S. Fowler W. Zhu L. Maynard F. Telang P. Vaska Y.S. Ding C. Wong J.M. Swanson Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers J Neurosci 23 2003 11461-11468
14. G.J. Wang N.D. Volkow L. Chang E. Miller M. Sedler R. Hitzemann W. Zhu J. Logan Y. Ma J.S. Fowler Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence Am J Psychiatry 161 2004 242-248
15. B.A. Vollm I.E. de Araujo P.J. Cowen E.T. Rolls M.L. Kringelbach K.A. Smith P. Jezzard R.J. Heal P.M. Matthews Methamphetamine activates reward circuitry in drug naive human subjects Neuropsychopharmacology 29 2004 1715-1722
16. H.C. Breiter R.L. Gollub R.M. Weisskoff D.N. Kennedy N. Makris J.D. Berke J.M. Goodman H.L. Kantor D.R. Gastfriend J.P. Riorden et al. Acute effects of cocaine on human brain activity and emotion Neuron 19 1997 591-611
17. G.A. Ricaurte L.S. Forno M.A. Wilson L.E. DeLanney I. Irwin M.E. Molliver J.W. Langston (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates JAMA 260 1988 51-55
18. U.D. McCann Z. Szabo U. Scheffel R.F. Dannals G.A. Ricaurte Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings Lancet 352 1998 433-437
19. D.M. Semple K.P. Ebmeier M.F. Glabus R.E. O'Carroll E.C. Johnstone Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users Br J Psychiatry 175 1999 63-69
20. R. Thomasius K. Petersen R. Buchert B. Andresen P. Zapletalova L. Wartberg B. Nebeling A. Schmoldt Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users Psychopharmacology (Berl) 167 2003 85-96
21. R. Buchert R. Thomasius F. Wilke K. Petersen B. Nebeling J. Obrocki O. Schulze U. Schmidt M. Clausen A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters Am J Psychiatry 161 2004 1181-1189
22. L. Reneman J. Booij K. de Bruin J.B. Reitsma F.A. de Wolff W.B. Gunning G.J. Den Heeten B.W. Van Den Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons Lancet 358 2001 1864-1869
23. J. Daumann R. Schnitker J. Weidemann K. Schnell A. Thron E. Gouzoulis-Mayfrank Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users Neuroreport 14 2003 1983-1987
24. J. Daumann B. Fimm K. Willmes A. Thron E. Gouzoulis-Mayfrank Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: A functional magnetic resonance imaging (fMRI) study Brain Res Cogn Brain Res 16 2003 479-487
25. J. Daumann Jr. T. Fischermann K. Heekeren A. Thron E. Gouzoulis-Mayfrank Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study Biol Psychiatry 56 2004 349-355
26. T.R. De La M. Farre Neurotoxicity of MDMA (ecstasy): The limitations of scaling from animals to humans Trends Pharmacol Sci 25 2004 505-508
27. A.L. Brody R.E. Olmstead E.D. London J. Farahi J.H. Meyer P. Grossman G.S. Lee J. Huang E.L. Hahn M.A. Mandelkern Smoking-induced ventral striatum dopamine release Am J Psychiatry 161 2004 1211-1218
28. 11C]raclopride PET Neuropsychopharmacology 29 2004 259-268
29. J.E. Rose F.M. Behm E.C. Westman R.J. Mathew E.D. London T.C. Hawk T.G. Turkington R.E. Coleman PET studies of the influences of nicotine on neural systems in cigarette smokers Am J Psychiatry 160 2003 323-333
30. 18)F] cyclofoxy in long-term, methadone-treated former heroin addicts J Pharmacol Exp Ther 295 2000 1070-1076
31. 11C]-Diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies J Pharmacol Exp Ther 2004 Epub
32. M.K. Greenwald C.E. Johanson D.E. Moody J.H. Woods M.R. Kilbourn R.A. Koeppe C.R. Schuster J.K. Zubieta Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers Neuropsychopharmacology 28 2003 2000-2009
33. I. Boileau J.M. Assaad R.O. Pihl C. Benkelfat M. Leyton M. Diksic R.E. Tremblay A. Dagher Alcohol promotes dopamine release in the human nucleus accumbens Synapse 49 2003 226-231
34. N.D. Volkow G.J. Wang L. Maynard J.S. Fowler B. Jayne F. Telang J. Logan Y.S. Ding S.J. Gatley R. Hitzemann et al. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: A preliminary study Psychiatry Res 116 2002 163-172
35. A. Heinz Dopaminergic dysfunction in alcoholism and schizophrenia - psychopathological and behavioral correlates Eur Psychiatry 17 2002 9-16
36. N.D. Volkow G.J. Wang J.S. Fowler J. Logan S.J. Gatley A. Gifford R. Hitzemann Y.S. Ding N. Pappas Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels Am J Psychiatry 156 1999 1440-1443
37. N.D. Volkow G.J. Wang J.S. Fowler P.P. Thanos J. Logan S.J. Gatley A. Gifford Y.S. Ding C. Wong N. Pappas P. Thanos Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study Synapse 46 2002 79-82
38. A.R. Hariri D.R. Weinberger Imaging genomics Br Med Bull 65 2003 259-270